- WKN: A1EMG5
- ISIN: DE000A1EMG56
- Land: Deutschland
Nachricht vom 22.10.2021 | 19:18
SPORTTOTAL AG resolves to issue a convertible bond
SPORTTOTAL AG / Key word(s): Issue of Debt
Disclosure of insider information pursuant to Article 17 MAR
Cologne, 22 October 2021. The Management Board of SPORTTOTAL AG (the "Company") has today resolved, with the approval of the Supervisory Board, to issue a convertible bond from contingent capital.
The Management Board and the Supervisory Board of SPORTTOTAL AG have today resolved to issue a convertible bond of up to EUR 6,973,000.00 with a term to maturity of five years and an interest rate of 8.5 % p.a. ("Convertible Bond"). The Convertible Bond is divided up into up to 6,973 partial debentures, each of which confer entitlement to subscribe to 1,000 new shares in the Company after expiration of a waiting period. Shareholders' subscription rights were excluded by way of resolution passed by the Annual General Meeting of 26 May 2021. The partial debentures will be offered to qualified institutional investors for purchase in the context of a private placement. The Convertible Bond is expected to be subscribed in several tranches, with 1,000 partial debentures being subscribed in the first tranche.
|Am Coloneum 2|
|Phone:||+49 (0)221 7 88 77 0|
|Fax:||+49 (0)221 7 88 77 199|
|Listed:||Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange|
|EQS News ID:||1242997|
|End of Announcement||DGAP News Service|
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
29. November 18:00 Bitcoin mit Verlusten: Ist das die Einstiegschance? Hier kommt die ...
29. November 18:29 Ölpreise erholt nach "kompletter Überreaktion" - BP, Exxon & Co im ...
29. November 18:33 CD Projekt: Die Stimmung dreht
29. November 19:59 Amazon: Auch hier bald die Nummer 1
29. November 20:18 "Danke" BioNtech: Hypoport-Boss ist ehrlich
30. November 2021
Original-Research: Gold Mountain Mining Corp. (von hanseatic stock publishing UG (haftungsbeschränkt)): Gold Mountain Mining Corp.
29. November 2021